183 related articles for article (PubMed ID: 8043941)
1. Potential role of oral anthracyclines in older patients with cancer.
Lasota WS; de Valeriola DL; Piccart MJ
Drugs Aging; 1994 May; 4(5):392-402. PubMed ID: 8043941
[TBL] [Abstract][Full Text] [Related]
2. A phase I clinical and pharmacokinetic study of the oral and the oral/intravenous administration of menogaril.
Weiss GR; Brown TD; Kuhn JG; Von Hoff DD; Earhart RH; Adams WJ; Brewer JE; Hosley JD; Kasunic DA
Invest New Drugs; 1993 Feb; 11(1):17-27. PubMed ID: 8349432
[TBL] [Abstract][Full Text] [Related]
3. Oral idarubicin. A review of its pharmacological properties and clinical efficacy in the treatment of haematological malignancies and advanced breast cancer.
Buckley MM; Lamb HM
Drugs Aging; 1997 Jul; 11(1):61-86. PubMed ID: 9237041
[TBL] [Abstract][Full Text] [Related]
4. Phase I clinical and pharmacokinetic trial of oral menogaril administered on three consecutive days.
Dodion P; de Valeriola D; Crespeigne N; Peeters B; Wery F; van Berchem C; Piccart M; Tueni E; Joggi J; Kenis Y
Eur J Cancer Clin Oncol; 1988 Jun; 24(6):1019-26. PubMed ID: 2970391
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of oral idarubicin in breast cancer patients with reference to antitumor activity and side effects.
Elbaek K; Ebbehøj E; Jakobsen A; Juul P; Rasmussen SN; Bastholt L; Dalmark M; Steiness E
Clin Pharmacol Ther; 1989 Jun; 45(6):627-34. PubMed ID: 2731405
[TBL] [Abstract][Full Text] [Related]
6. [Clinical pharmacology of idarubicin].
Robak T
Acta Haematol Pol; 1993; 24(4):315-26. PubMed ID: 8303977
[TBL] [Abstract][Full Text] [Related]
7. Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.
Hollingshead LM; Faulds D
Drugs; 1991 Oct; 42(4):690-719. PubMed ID: 1723369
[TBL] [Abstract][Full Text] [Related]
8. [New anthracyclines].
Ogawa M; Ariyoshi Y
Gan To Kagaku Ryoho; 1993 Jan; 20(1):27-33. PubMed ID: 8422185
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of, and toxicoses associated with, oral idarubicin administration in cats with neoplasia.
Moore AS; Ruslander D; Cotter SM; Rand WM; L'Heureux DA
J Am Vet Med Assoc; 1995 May; 206(10):1550-4. PubMed ID: 7775231
[TBL] [Abstract][Full Text] [Related]
10. Idarubicin: an anthracycline antineoplastic agent.
Cersosimo RJ
Clin Pharm; 1992 Feb; 11(2):152-67. PubMed ID: 1551297
[TBL] [Abstract][Full Text] [Related]
11. [Oral idarubicin in treatment of advanced breast carcinoma].
Kerpel-Fronius S; Heinisch H
Zentralbl Gynakol; 1996; 118(10):587-9. PubMed ID: 8999720
[TBL] [Abstract][Full Text] [Related]
12. Oral idarubicin pharmacokinetics--correlation of trough level with idarubicin area under curve.
Schleyer E; Kühn S; Rührs H; Unterhalt M; Kaufmann CC; Kern W; Braess J; Sträubel G; Hiddemann W
Leukemia; 1997 Dec; 11 Suppl 5():S15-21. PubMed ID: 9436933
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and acute cardiovascular effects of menogaril in patients with metastatic tumors.
Piergies AA; Benson AB
Int J Clin Pharmacol Ther; 1995 Feb; 33(2):63-9. PubMed ID: 7757312
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of menogaril in patients with previously treated multiple myeloma or chronic lymphocytic leukemia.
Kucuk O; Kilton L; Wade JL; Blough R; Benson AB
Am J Clin Oncol; 2000 Aug; 23(4):379-83. PubMed ID: 10955868
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of idarubicin after oral administration in elderly leukemic patients.
Robert J; Rigal-Huguet F; Huet S; Pris J; Hurteloup P
Leukemia; 1990 Mar; 4(3):227-9. PubMed ID: 2179640
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of oral idarubicin (4-demethoxidaunorubicin) in previously untreated elderly patients with non-Hodgkin's lymphoma.
Errante D; Sorio R; Zagonel V; Carbone A; Monfardini S; Tirelli U
Am J Clin Oncol; 1991 Jun; 14(3):243-5. PubMed ID: 2031512
[TBL] [Abstract][Full Text] [Related]
17. Anthracyclines active via the oral route: luxury or necessity?
Piccart MJ; de Valeriola D; Tomiak E
Ann Oncol; 1992 Mar; 3(3):181-2. PubMed ID: 1534020
[No Abstract] [Full Text] [Related]
18. Anticancer activities of orally administered menogaril against human stomach and breast cancers implanted in nude mice.
Inaba M; Sato S; Yamori T; Tashiro T; Ohnishi Y; Maruo K; Ueyama Y; Tsuruo T
Anticancer Res; 1992; 12(6B):1953-6. PubMed ID: 1295442
[TBL] [Abstract][Full Text] [Related]
19. Activity of menogaril against various malignant lymphoma cell lines and a human lymphoma xenograft in mice.
Yoshida M; Fujioka A; Nakano K; Yuasa C; Toko T; Takeda S; Unemi N
Anticancer Res; 1996; 16(5A):2875-9. PubMed ID: 8917401
[TBL] [Abstract][Full Text] [Related]
20. Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patients.
Toffoli G; Sorio R; Aita P; Crivellari D; Corona G; Bearz A; Robieux I; Colussi AM; Stocco F; Boiocchi M
Clin Cancer Res; 2000 Jun; 6(6):2279-87. PubMed ID: 10873078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
